ArticleJournal for immunotherapy of cancer2021

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.

Nurulhuda Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.